Management Of Lung Cancer

Abstract

Background: The management of lung cancer has witnessed substantial advancements, necessitating a multidisciplinary approach that integrates various specialties to enhance patient outcomes. The literature reveals critical insights into the importance of timely diagnosis, treatment strategies, and the role of palliative care in managing this complex disease. Literature Review: (Kochovska et al., 2020) further contribute to this discussion by exploring the integration of early palliative care in lung cancer management. Their systematic review and meta-analysis reveal mixed evidence regarding the effectiveness of early palliative care interventions, suggesting that while it can enhance symptom management and quality of life, the impact on overall patient outcomes remains uncertain. They advocate for personalized care plans that align with patients' unique needs, emphasizing the importance of integrating palliative care into the treatment trajectory. (Daniel Humberto Pozza & Ramon Bezerra Andrade de Mello, 2022) delve into treatment sequencing strategies, highlighting the significance of predictive biomarkers in tailoring therapies for lung cancer patients. They note advancements in histopathology and molecular diagnostics that have improved survival rates, stressing the necessity for comprehensive initial assessments to determine optimal treatment pathways. This personalized approach is increasingly recognized as vital in effective lung cancer management. (Zarinshenas et al., 2023) address barriers to effective management, particularly in early-stage lung cancer screening and biomarker testing. They identify underutilization of low-dose computed tomography (LDCT) and various challenges that hinder broader implementation of screening programs, which are crucial for early detection and improved outcomes. Conclusion: In conclusion, the literature on lung cancer management collectively underscores the necessity of a multidisciplinary approach that incorporates timely diagnosis, personalized treatment strategies, and the integration of palliative care. The advancements in molecular diagnostics and targeted therapies present promising avenues for improving patient outcomes; however, challenges such as screening underutilization and resistance to treatment must be addressed to optimize management strategies further.